Journal Logo

Research Article: Study Protocol Systematic Review

The efficacy and safety of acupuncture for perimenopause symptom compared with different sham acupuncture control groups

A protocol of systematic review and meta-analysis

He, Qiujun MDa; Ren, Yajing MDb; Wang, Yanqiu MDc; Zhang, Feng MDd; Zhang, Sanyin PhDb,∗

Author Information
doi: 10.1097/MD.0000000000019366
  • Open

Abstract

1 Introduction

Perimenopause syndrome, referred also as a climacteric syndrome. The perimenopausal symptoms include premenopause, menopause and postmenopause. Perimenopause is a normal and important aging phenomenon that occurs in women's life. Although some women have no obvious symptoms during this period, Most women still suffer from perimenopausal symptoms that affect health, work, life, and economic status.[1–8] The most common and frequent episode of perimenopausal symptoms is hot flashes,[2,9] which affect around 75% of menopausal women,[10–13] In addition, the incidence of menopause insomnia is as high as 39% to 47%,[14,15] Other symptoms include anxiety, fatigue, irritability, weight gain, night sweats, vaginal dryness, and urinary incontinence.[16–19] These perimenopausal symptoms begin 1 to 2 years before menopause and may persist from 6 months to more than 10 years.[2,20] These menopause symptoms may be caused by the perimenopause itself, or it may be a chain reaction caused by one of them. These chain reactions may cause or promote the occurrence of diseases such as high blood pressure, diabetes, obesity, cardiovascular diseases, psychological diseases and so on while accelerating aging. Hot flashes can affect women's work and quality of life, Of course, sleep will also be affected.[3–5,7,8,21] In addition, hard to falling sleep has been shown to associate strongly with anxiety,[22,23] Insomnia and anxiety of menopausal women have a chain effect and cause depression.[24] So it can be seen that the symptoms of perimenopause are not single, there may be multiple symptoms. It may even promote or cause other diseases.[25–27]

What is the cause of such a wide-ranging, long-lasting disease? The etiology of perimenopausal syndrome, which is now known to be due to the decline or disappearance of ovarian function, hormone levels fluctuations, and instability.[16,17,28,29] Therefore, hormone replacement therapy has become the most effective treatment for the perimenopausal syndrome.[13,17,30–32] But the Women's Health Initiative (WHI) reported an increase in cases of Cardiovascular disease after hormone therapy.[33–35] Considering the duration of perimenopausal symptoms, hormones are not suitable for long-term use.[36–39] Therefore, more people choose to try non-hormonal replacement therapy,[40–44] acupuncture is one of them.[45–47] Acupuncture treatments include traditional hand acupuncture,[48] electroacupuncture,[49] ear acupuncture,[50] laser acupuncture,[51] acupressure,[52] moxibustion,[53] etc. Research reports that acupuncture can relieve perimenopausal symptoms and improve quality of life.[45,46,54] Although according to research reports that the efficacy of acupuncture has obvious advantages compared with the waiting group[46] or the usual care controls,[55] it also has certain effects compared with western medicine control,[56] it compared with fake acupuncture is highly controversial.[46,57,58] The related meta-analysis studies also showed it.[59,60] A meta-analysis study by Li et al Showed that The number of RCTs that compared the acupuncture control to a sham group is too small, and some studies had a flawed methodology, making it difficult for them to generate reliable conclusions about the efficacy of acupuncture.[61] Therefore, the systematic review and meta-analysis hope to further analyze the efficacy and safety of acupuncture in the treatment of perimenopausal symptoms, focusing on the analysis of different acupuncture interventions and different controls, especially sham acupuncture controls.

2 Methods

2.1 protocol design

This meta-analysis and systematic review will be based on the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols (PRISMA-P) for systematic reviews of interventions.[62,63] The ethical approval is not required because there is no direct involvement of human.

2.2 Eligibility criteria

2.2.1 Type of participants (P)

The patients in this study will include the woman who transitional period before and after menopause.[28] These women are 40 to 55 years and have perimenopausal symptoms (hot flashes, night sweats, anxiety, palpitations, fatigue, headaches, etc).

2.2.2 Type of interventions (I)

The acupuncture treatment methods of the intervention group included traditional hand acupuncture, electroacupuncture, auricular acupuncture, moxibustion, laser acupuncture, acupressure, etc. There are no acupuncture points, frequencies, and needle retention times.

2.2.3 Type of comparisons (C)

The control group included waiting, routine care, medicine control, Sham acupuncture (invasive/noninvasive), etc. The waiting control and routine care control will not be treated with any acupuncture; the medicine control includes Chinese medicine control and western medicine control; the sham acupuncture control includes non-invasive control (Clinical trial research uses special equipment to prevent the needle from penetrating into the skin but to make patients think they are receiving acupuncture treatment)[48,58] and invasive control (the needle penetrates the skin but does not work. It does not require the feeling of “Deqi” Or acupuncture in places without acupoints).[64,65]

2.2.4 Type of outcome measures (O)

2.2.4.1 Primary outcome
  • (1) The flushes per 24 hours.
  • (2) The frequency of hot flashes.
  • (3) The severity of hot flashes.
  • (4) The menopause-related symptom score (the Kupperman index KI, the Menopause rating scale MRS).
  • (5) The treatment efficacy.
  • (6) The adverse event.
2.2.4.2 secondary outcome
  • (1) Hormone level (FSH, LE, E2).
  • (2) Menopausal quality of life score (WHOQOL).
  • (3) Depression scale assessment.
  • (4) Sleep quality assessment.
  • (5) The expected value of acupuncture.
  • (6) Intervention acupuncture experience.

2.2.5 Type of study (S)

The design method is the literature of randomized controlled trials (RCTs), no date or language limits for publication were set.

2.3 Exclusion criteria

The following conditions will be excluded:

  • (1) (a) Received any other alternative therapies 4 weeks before enrollment; (b) ovarian cyst, tumor, oophorectomy, or hysterectomy; (c) severe metabolic, thrombo-embolic or endocrine disease, uncontrolled hypertension or use of sedatives, anxiolytic or antidepressant medication, or use of narcotics.
  • (2) While this study will exclude any literature regarding acupuncture combined with drugs as the intervention group, as well as the literature that other drugs can be used at the same time during acupuncture treatment.
  • (3) Non-randomized controlled trials will be excluded.
  • (4) We will exclude the study that data cannot be extracted, duplicate data, and cannot be provided in full text. However, for studies with insufficient data, we will try to contact the authors of these studies to provide more complete data.

2.4 Data source

We will perform a systematic clinical trial research search in databases of PubMed, Embase, Cochrane, Web of Science, CBM, CNKI, WAN FANG, and VIP. If necessary, we will also Search some trial research registration platforms. No date or language limits for publication were set. Search terms for this study include perimenopause, hot flashes, acupuncture, acupressure, electroacupuncture, ear acupuncture, RCTs, etc. The search strategy is designed by the combination of MeSH words, free words and truncation search. The specific search strategies are listed in Table 1.

T1
Table 1:
Search strategy in Pubmed database.

2.5 Study selection

All results retrieved from the database will be imported into the EndNote software (X8), and an automatic search for duplicate studies will be set up. After excluding duplicate studies, the 2 authors will independently screen the remaining literature by title and abstract. If the title and abstract include exclusion criteria or do not include inclusion criteria, create a “Title Abstract Exclusion ” in endnote and move the clinical trial study into it. The remaining clinical trials will be searched for full text. Two authors will assess eligibility for the full text of these studies, and create “Publication type” “Study aim/design” “Intervention” “secondary analysis” in endnote according to the reasons for exclusion. The excluded clinical trial studies were moved into the corresponding group according to the reasons for exclusion. Two authors should contact the author of the study if the clinical trial studies are classified as an “insufficient” category due to unclear information or missing data. In addition, all processes will be performed independently by the 2 authors, then discuss the results together. the third review author will identify the study When the opinions of the 2 authors diverged. The select study flowchart Figure 1.

F1
Figure 1:
The flow chart of study selection has been designed under the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocols).

2.6 Data extraction

Data will be extracted independently by reviewers using a standardized form. Extracted information included:

  • (1) Publication features (title, authors, year of publication, journal);
  • (2) Characteristics of research objects (number of participants, age and sex);
  • (3) Measures of intervention/control group (Acupuncture type, acupoints, needle retention time, times, etc);
  • (4) Outcome indicators (For example MRS, hot flashes, menopause index, etc);
  • (5) The key information of biased risk assessment;
  • (6) Outcome data will be divided into the pre-treatment data table, the in-treatment data table, and the follow-up data table according to the clinical study time so that the change value can be calculated later. (mean, SD, CI, etc).

2.7 Risk assessment

In this study, 2 researchers will conduct risk assessments independently. After the assessment, the results of the cross-check can be discussed and resolved by other researchers and 2 researchers. The final decision will be made by the third author When the 2 authors have a controversy with the assessment. The bias risk assessment included in the study will conduct using the bias risk assessment tool recommended by Cochrane manual version 5.1.0 for RCT. the valuation content includes random method design; assignment concealment; whether to use blind method for subjects and researchers; whether the result data is complete, whether there is a selective report of research results, etc. The rating is divided into high risk, low risk, and unclear. The assessment will be performed using Review Manager software 5.3 software and a risk assessment form will be drawn.

2.8 Insufficient data

We will contact the first corresponding authors of the included studies to get missing or insufficient trial data by email. If the data cannot be obtained. We will analyze whether the missing data has an impact on the meta-analysis, and if the impact is large, this clinical trial study will be excluded.

2.9 Data analysis

In this study, Revman 5.3 and STATA 13.0 statistical software will use for analysis. If the includes outcome indicator include 10 or more articles, we will use a funnel chart to test the risk of publication bias.

2.9.1 Measures of curative effect

The confidence intervals (CIs) will be set to 95% for both continuous outcomes and dichotomous outcomes. The dichotomous outcomes (the effective rate and adverse events) will analyze the rate ratio. For continuous variables, the mean and SD of the change value were will calculate according to the baseline value and endpoint value of the extracted data. If the included data is not mean and SD, calculate and analyze according to the formula.

2.9.2 Assessment of heterogeneity

The heterogeneity in the study will be analyzed by the X2 test (the test level was α = 0.1), and evaluate with I2 statistics. The fixed effects model will be used for the analysis of this outcome indicator, when Its heterogeneity test result is I2 < 50% (No heterogeneity). if the heterogeneity test result is I2 ≥ 50% (have heterogeneity), after excluding obvious clinical and methodological heterogeneity, the random-effects model will be used for the analysis of this outcome indicator.

2.9.3 Subgroup analysis

The subgroup analysis is key in this study design.

  • (1) We will perform subgroup analysis on outcome indicators with different controls. The subgroup analysis of the control group includes waiting, routine care, medicine control, Sham acupuncture (invasive/noninvasive), etc.
  • (2) We will also perform a subgroup analysis of outcome indicators with different interventions. The subgroup analysis of the intervention group includes ear acupuncture, electroacupuncture, moxibustion, acupressure, traditional hand acupuncture, etc.

2.9.4 Sensitivity analysis

When there is an insufficient sample size, missing data, quality of analysis and research, methodological elements, etc, we will perform sensitivity analysis. The specific implementation is to eliminate the single study, then analyze again, and evaluate the difference between the eliminated results and the original combined results

3 Discuss

Hormone replacement therapy has become the most effective treatment for perimenopausal syndrome,[16,17,28,29] but some studies have shown that hormones are not suitable for long-term use.[36–39] Therefore, more people choose to try non-hormonal replacement therapy,[40–44] acupuncture is one of them.[45–47] There are more and more clinical trials of acupuncture treatment for perimenopause, and some meta-analysis researches related to it have also appeared.[54,59–61] These studies demonstrate that acupuncture has a certain effect on one or more of the outcome indicators of perimenopause symptoms compared with the waiting group[46] or the routine care group.[55] But the comparison with sham acupuncture is still controversial.[57,58] At the same time, these studies have analyzed the effects of acupuncture on perimenopausal symptoms, but there is no comprehensive analysis comparing the effects of different acupuncture intervention methods on the outcome indicators of perimenopausal symptoms, which may be the reason for the insufficient sample size at that time.

Therefore, it is necessary to further analyze the safety and efficacy of acupuncture in the treatment of perimenopausal symptoms. Except for routine efficacy and safety analysis, this study focused on subgroup analysis. On the one hand, the subgroup analysis of the control group includes waiting, routine care, medicine control, Sham acupuncture, etc. The sham acupuncture control includes non-invasive control (Clinical trial research uses special equipment to prevent the needle from penetrating the skin but to make patients think they are receiving acupuncture treatment)[48,58] and invasive control (the needle penetrates the skin but does not work. It does not require the feeling of “Deqi” Or acupuncture in places without acupoints).[64,65] On the other hand, intervention subgroup analysis includes ear acupuncture, electroacupuncture, moxibustion, acupressure, traditional hand acupuncture, etc. The ultimate objective of this study is to hope that the conclusions drawn from the analysis can provide more useful evidence for the clinical operation and clinical research of acupuncture treatment of perimenopausal symptoms.

Author contributions

Conceptualization: Qiujun He.

Data curation: Qiujun He, Yajing Ren, Yanqiu Wang.

Formal analysis: Qiujun He, Yanqiu Wang, Feng Zhang.

Methodology: Qiujun He, Yajing Ren.

Project administration: Qiujun He.

Supervision: Sanyin Zhang, Peng Yang.

Validation: Qiujun He, Yanqiu Wang, Feng Zhang.

Writing – original draft: Qiujun He.

Writing – review & editing: Qiujun He, Yanqiu Wang.

Qiujun He orcid: 0000-0002-1679-9625.

References

[1]. Perez JA, Garcia FC, Palacios S, et al. Epidemiology of risk factors and symptoms associated with menopause in Spanish women. Maturitas 2009;62:30–6.
[2]. Whiteley J, Wagner JS, Bushmakin A, et al. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause 2013;20:518–24.
[3]. Williams RE, Levine KB, Kalilani L, et al. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 2009;62:153–9.
[4]. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–54.
[5]. Fuh J-L, Wang S-J, Lee S-J, et al. Quality of life and menopausal transition for middle-aged women on Kinmen island. Qual Life Res 2003;12:53–61.
[6]. Geukes M, van Aalst MP, Robroek SJ, et al. The impact of menopause on work ability in women with severe menopausal symptoms. Maturitas 2016;90:3–8.
[7]. Ne A, M O, Ka M, et al. Health-related quality of life in a multiethnic sample of middle-aged women Study of Women's Health Across the Nation (SWAN). Med Care 2003;41:1262–76.
[8]. Kumari M, Stafford M, Marmot M. The menopausal transition was associated in a prospective study with decreased health functioning in women who report menopausal symptoms. J Clin Epidemiol 2005;58:719–27.
[9]. Archer DF, Sturdee DW, Baber R, et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011;14:515–28.
[10]. Pachman DR, Jones JM, Loprinzi CL. Management of menopause-associated vasomotor symptoms Current treatment options, challenges and future directions. Int J Womens Health 2010;2:123–35.
[11]. Col NF, Guthrie JR, Politi M, et al. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009;16:453–7.
[12]. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9.
[13]. Stearns V, Ullmer L, Lopez JF, et al. Hot flushes. Lancet 2002;360:1851–61.
[14]. Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin North Am 2011;38:567–86.
[15]. Slopien R, Wichniak A, Pawlak M, et al. Disturbances of sleep continuity in women during the menopausal transition. Psychiatr Pol 2015;49:615–23.
[16]. Prairie BA, Wisniewski SR, Luther J, et al. Symptoms of depressed mood, disturbed sleep, and sexual problems in midlife women: cross-sectional data from the Study of Women's Health Across the Nation. J Womens Health (Larchmt) 2015;24:119–26.
[17]. Nelson HD. Menopause. Lancet 2008;371:760–70.
[18]. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 2006;96:1226–35.
[19]. Greenblum CA, Rowe MA, Neff DF, et al. Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life. Menopause 2013;20:22–7.
[20]. Roberts H, Hickey M. Managing the menopause: an update. Maturitas 2016;86:53–8.
[21]. Blumel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85.
[22]. Terauchi M, Hiramitsu S, Akiyoshi M, et al. Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas 2012;72:61–5.
[23]. Parry BL, Fernando Martinez L, Maurer EL, et al. Sleep, rhythms and women's mood. Part II. Menopause. Sleep Med Rev 2006;10:197–208.
[24]. Sǎgsöz N, Ǒguztürkx Ö, Bayram M, et al. Anxiety and depression before and after the menopause. Arch Gynecol Obstet 2001;264:199–202.
[25]. Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;112:689–90.
[26]. Yazdi Z, Sadeghniiat-Haghighi K, Ziaee A, et al. Influence of sleep disturbances on quality of life of Iranian menopausal women. Psychiatry J 2013;2013:907068.
[27]. Sun D, Shao H, Li C, et al. Sleep disturbance and correlates in menopausal women in Shanghai. J Psychosom Res 2014;76:237–41.
[28]. Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril 2012;97:843–51.
[29]. Kase NG. Impact of hormone therapy for women aged 35 to 65 years from contraception to hormone replacement. Gend Med 2009;6:37–59.
[30]. Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000;182:277–82.
[31]. Sarri G, Davies M, Lumsden MA, et al. Diagnosis and management of menopause: summary of NICE guidance. BMJ 2015;351:h5746.
[32]. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 2001;98:702.
[33]. James V, Lacey J, Mink PJ, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002;288:334–41.
[34]. Creasman WT. Estrogen and cancer. Gynecol Oncol 2002;86:1–9.
[35]. Chen C-L, Weiss NS, Newcomb P, et al. Hormone replacement therapy in relation to breast cancer. JAMA 2002;287:734–41.
[36]. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative: a randomized trial. JAMA 2003;289:2673–84.
[37]. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–34.
[38]. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy Heart and Estrogen progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49–57.
[39]. Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209–18.
[40]. Klein SD, Frei-Erb M, Wolf U. Usage of complementary medicine across Switzerland: results of the Swiss Health Survey 2007. Swiss Med Wkly 2012;142:w13666.
[41]. Widmer M, Donges A, Wapf V, et al. The supply of complementary and alternative medicine in Swiss hospitals. Forsch Komplementmed 2006;13:356–61.
[42]. Rossler W, Lauber C, Angst J, et al. The use of complementary and alternative medicine in the general population: results from a longitudinal community study. Psychol Med 2007;37:73–84.
[43]. Hickey M, Szabo RA, Hunter MS. Non-hormonal treatments for menopausal symptoms. BMJ 2017;359:j5101.
[44]. van der Sluijs CP, Bensoussan A, Liyanage L, et al. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14:397–403.
[45]. Liu Z, Ai Y, Wang W, et al. Acupuncture for symptoms in menopause transition: a randomized controlled trial. Am J Obstet Gynecol 2018;219:373e1- e10.
[46]. Avis NE, Coeytaux RR, Isom S, et al. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause 2016;23:626–37.
[47]. Fu C, Zhao N, Liu Z, et al. Acupuncture improves peri-menopausal insomnia: a randomized controlled trial. Sleep 2017;40: doi: 10.1093/sleep/zsx153.
[48]. Ee C, Xue C, Chondros P, et al. Acupuncture for menopausal hot flashes: a randomized trial. Ann Intern Med 2016;164:146–54.
[49]. Sandberg M, Wijma K, Wyon Y, et al. Effects of electro–acupuncture on psychological distress in postmenopausal women. Complement Ther Med 2002;10:161–9.
[50]. Zhanling S, Yabei J, Huifang J. Ear acupuncture for perimenopause syndrome: a multi-centered randomized controlled trial. J Acupunct Tuina Sci 2011;9:287–90.
[51]. Eam E, Mm E, Hah A, et al. Effect of aerobic exercises versus laser acupuncture in treatment of postmenopausal hot flushes: a randomized controlled trial. J Phys Ther Sci 2018;30:328–31.
[52]. Armand M, Ozgoli G, Giti RH, et al. Effect of acupressure on early complications of menopause in women referring to selected health care centers. Iran J Nurs Midwifery Res 2017;22:237–42.
[53]. Shen J, Ai B, Shen M. Effectiveness of mild moxibustion for sub-health conditions in pre- and post-menopausal women: a randomized controlled clinical trial. Med Sci Monit 2018;24:2907–11.
[54]. Chiu HY, Hsieh YJ, Tsai PS. Acupuncture to reduce sleep disturbances in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Obstet Gynecol 2016;127:507–15.
[55]. Kim KH, Kang KW, Kim DI, et al. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial. Menopause 2010;17:269–80.
[56]. Li S, Li ZF, Wu Q, et al. A multicenter, randomized, controlled trial of electroacupuncture for perimenopause women with mild-moderate depression. Biomed Res Int 2018;2018:5351210.
[57]. Painovich JM, Shufelt CL, Azziz R, et al. A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause 2012;19:54–61.
[58]. Sunay D, Ozdiken M, Arslan H, et al. The effect of acupuncture on postmenopausal symptoms and reproductive hormones: a sham controlled clinical trial. Acupunct Med 2011;29:27–31.
[59]. Befus D, Coeytaux RR, Goldstein KM, et al. Management of menopause symptoms with acupuncture: an umbrella systematic review and meta-analysis. J Altern Complement Med 2018;24:314–23.
[60]. Chiu HY, Pan CH, Shyu YK, et al. Effects of acupuncture on menopause-related symptoms and quality of life in women in natural menopause: a meta-analysis of randomized controlled trials. Menopause 2015;22:234–44.
[61]. Li W, Luo Y, Fu W, et al. Acupuncture may improve quality of life in menopausal women: a meta-analysis of randomized controlled trials. Complement Med Res 2018;25:183–90.
[62]. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
[63]. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647.
[64]. Nedeljkovic M, Tian L, Ji P, et al. Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial. Menopause 2014;21:15–24.
[65]. Vincent A, Barton DL, Mandrekar JN, et al. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 2007;14:45–52.
Keywords:

acupuncture; meta-analysis; perimenopausal symptoms; sham acupuncture control

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.